Monocyte Subsets in Cardiovascular Disease: A Biomarker Perspective

Area of Science:

• Cardiovascular Research
• Immunology
• Atherosclerosis Pathogenesis

Background:

• Atherosclerosis development involves endothelial dysfunction, immune dysregulation, and lipid accumulation.
• Monocytes play a sequential role in the pathology of atherosclerosis.
• Recent research has expanded understanding of monocyte subsets in this disease.

Purpose of the Study:

• To review recent basic research and clinical findings on monocyte subsets in atherosclerosis.
• To re-evaluate the relevance of monocyte subsets as surrogate biomarkers in coronary artery disease.
• To update the understanding since the European Society of Cardiology consensus document.

Main Methods:

• Literature review of recent basic research and clinical studies.
• Analysis of data on monocyte subset involvement in atherosclerosis.
• Synthesis of findings related to biomarker potential.

Main Results:

• Emerging data highlight the sequential involvement of specific monocyte subsets in atherosclerosis.
• Clinical findings suggest potential utility of these subsets as biomarkers.
• The role of monocytes in disease progression is increasingly understood.

Conclusions:

• Monocyte subsets are critical players in atherosclerosis pathogenesis.
• Further research is warranted to validate their role as reliable biomarkers for coronary artery disease.
• Updated understanding supports their potential clinical application.